DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.

RecruitingObservational study

Who can join

Ages 18 and older · All sexes

Full eligibility criteria

Inclusion Criteria:

* Patients who have undergone PVE/HVE or technical variations on this procedure
* 18 Years and older
* Men and women

About the study

The DRAGON registry aims to collect data on combined portal and hepatic vein embolization (PVE/HVE) for liver tumors, a technique expected to enhance liver regeneration compared to standard PVE. This collaborative registry focuses on identifying associations between baseline clinical/imaging parameters, clinical outcomes, and safety for patients undergoing PVE/HVE.

Sponsor: Maastricht University Medical Center · Participants: 350 · Started: Mar 16, 2021

Contact the study team

Fenna Van der Zijden, Dr. · Phone: +316 40911632

Official record on ClinicalTrials.gov — NCT07717437

Locations in the U.S.

Illinois	Rush University Medical Center, Chicago
Minnesota	Mayo Clinic, Rochester
Ohio	Cleveland Clinic, Cleveland

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.